�鶹��Ժ

CU Boulder researcher Linda Watkins and CU startups Beryl Therapeutics Inc., Modendo Inc. and TissueForm Inc. are among 37 companies and researchers awarded Proof of Concept and Early-Stage Capital Retention grants through the Colorado Office of Economic Development and International Trade (OEDIT).

CU Boulder researchers have identified a surprising new player in ALS (amyotrophic lateral sclerosis)—an ancient, virus-like protein. With funding from the ALS Association, the National Institutes of Health, and Venture Partners at CU Boulder, Alexandra Whiteley's lab is now working to understand the molecular pathways involved and to find a way of inhibiting the rogue protein.

NIST—Researchers at the National Institute of Standards and Technology (NIST) and CU Boulder have fabricated a novel device that could dramatically boost the conversion of heat into electricity. If perfected, the technology could help recoup some of

Say “hello” to the robots of the future: They’re soft and flexible enough to bounce off walls or squeeze into tight spaces. And when you’re done with them, you can toss these machines into a compost bin to decompose.

Vitro3D, a CU Boulder startup pioneering volumetric 3D printing for life sciences, just closed its first investment round of $1.3 million. The hard-won vote of confidence from the investment community will allow the promising new venture to pursue ambitious technical advances while continuing to build critical business capacity. 

Keith “Bang Bang” McCurdy is taking HYPRSKN—the microscopic skin implants with adaptive, color-changing in-skin pigments developed by Carson Bruns and Jesse Butterfield of CU Boulder's ATLAS Institute—to the next level with real tattoo ink that you can “turn on” or off using different wavelengths of UV and white light.

Chemical & Engineering News (C&EN) identified young scientists who are trying to solve formidable global problems. Lim was recognized for developing organic molecules that spur on light-powered reactions.

Researchers at CU Boulder have created a platform that can develop effective and highly specific peptide nucleic acid therapies for use against any bacteria within just one week. The Facile Accelerated Specific Therapeutic (FAST) platform was created by Associate Professor Anushree Chatterjee and her team within the Department of Chemical and Biological Engineering.

Distinguished Engineering Professor Christopher Bowman, who is a serial inventor working with Venture Partners, has been elected to the National Academy of Engineering, one of the highest professional distinctions accorded to engineers. Bowman was chosen for his innovations related to photopolymerization, a process that uses light to trigger reactions that form new polymers. These polymers are used for an array of medical and technological applications, such as 3D printing, dental fillings, medical devices and augmented reality displays.

The National Academy of Inventors (NAI) today announced that CU Boulder researchers and spinout founders Mark Rentschler, Greg Rieker and Tin Tin Su have been designated as NAI Senior Members in recognition of their impact on society through extraordinary innovation.